ParkinsonCanadaV1, Main, Exploration, bibRecord, 003801

Ropinirole and pramipexole, the new agonists

Identifieur interne : 003801 ( Main/Exploration ); précédent : 003800; suivant : 003802

Ropinirole and pramipexole, the new agonists

Auteurs : D. E. Hobson [Canada] ; E. Pourcher [Canada] ; W. R. W. Martin [Canada]

Source :

Canadian journal of neurological sciences [ 0317-1671 ] ; 1999.

RBID : Pascal:99-0456205

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Ropinirole, Agoniste, Récepteur dopaminergique D2, Pramipexole, Antiparkinsonien, Chimiothérapie, Traitement, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Agonist, Animals, Antiparkinson Agents (metabolism), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Benzothiazoles, Binding, Competitive, Chemotherapy, Clinical Trials as Topic, D2 Dopamine receptor, Dopamine Agonists (metabolism), Dopamine Agonists (therapeutic use), Human, Humans, Indoles (metabolism), Indoles (therapeutic use), Parkinson Disease (drug therapy), Parkinson disease, Pramipexole, Receptors, Dopamine (metabolism), Ropinirole, Thiazoles (metabolism), Thiazoles (therapeutic use), Treatment.
MESH :
- chemical , metabolism : Antiparkinson Agents, Dopamine Agonists, Indoles, Receptors, Dopamine, Thiazoles.
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Indoles, Thiazoles.
- drug therapy : Parkinson Disease.
- Animals, Benzothiazoles, Binding, Competitive, Clinical Trials as Topic, Humans.

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ropinirole and pramipexole, the new agonists</title>
<author><name sortKey="Hobson, D E" sort="Hobson, D E" uniqKey="Hobson D" first="D. E." last="Hobson">D. E. Hobson</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of Manitoba</s1>
<s2>Winnipeg, Manitoba</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
<orgName type="university">Université du Manitoba</orgName>
</affiliation>
</author>
<author><name sortKey="Pourcher, E" sort="Pourcher, E" uniqKey="Pourcher E" first="E." last="Pourcher">E. Pourcher</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Laval University</s1>
<s2>Quebec City, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Laval University</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Martin, W R W" sort="Martin, W R W" uniqKey="Martin W" first="W. R. W." last="Martin">W. R. W. Martin</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>University of Alberta</s1>
<s2>Edmonton, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>University of Alberta</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0456205</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0456205 INIST</idno>
<idno type="RBID">Pascal:99-0456205</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D40</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001183</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C28</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000C28</idno>
<idno type="wicri:doubleKey">0317-1671:1999:Hobson D:ropinirole:and:pramipexole</idno>
<idno type="wicri:Area/Main/Merge">003D81</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10451757</idno>
<idno type="wicri:Area/PubMed/Corpus">001692</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001692</idno>
<idno type="wicri:Area/PubMed/Curation">001692</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001692</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001692</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001692</idno>
<idno type="wicri:Area/Ncbi/Merge">000045</idno>
<idno type="wicri:Area/Ncbi/Curation">000045</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000045</idno>
<idno type="wicri:doubleKey">0317-1671:1999:Hobson D:ropinirole:and:pramipexole</idno>
<idno type="wicri:Area/Main/Merge">003B61</idno>
<idno type="wicri:Area/Main/Curation">003801</idno>
<idno type="wicri:Area/Main/Exploration">003801</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ropinirole and pramipexole, the new agonists</title>
<author><name sortKey="Hobson, D E" sort="Hobson, D E" uniqKey="Hobson D" first="D. E." last="Hobson">D. E. Hobson</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of Manitoba</s1>
<s2>Winnipeg, Manitoba</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
<orgName type="university">Université du Manitoba</orgName>
</affiliation>
</author>
<author><name sortKey="Pourcher, E" sort="Pourcher, E" uniqKey="Pourcher E" first="E." last="Pourcher">E. Pourcher</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Laval University</s1>
<s2>Quebec City, Quebec</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Laval University</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Martin, W R W" sort="Martin, W R W" uniqKey="Martin W" first="W. R. W." last="Martin">W. R. W. Martin</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>University of Alberta</s1>
<s2>Edmonton, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>University of Alberta</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Animals</term>
<term>Antiparkinson Agents (metabolism)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Benzothiazoles</term>
<term>Binding, Competitive</term>
<term>Chemotherapy</term>
<term>Clinical Trials as Topic</term>
<term>D2 Dopamine receptor</term>
<term>Dopamine Agonists (metabolism)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Human</term>
<term>Humans</term>
<term>Indoles (metabolism)</term>
<term>Indoles (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Pramipexole</term>
<term>Receptors, Dopamine (metabolism)</term>
<term>Ropinirole</term>
<term>Thiazoles (metabolism)</term>
<term>Thiazoles (therapeutic use)</term>
<term>Treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Indoles</term>
<term>Receptors, Dopamine</term>
<term>Thiazoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Indoles</term>
<term>Thiazoles</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Benzothiazoles</term>
<term>Binding, Competitive</term>
<term>Clinical Trials as Topic</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Ropinirole</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique D2</term>
<term>Pramipexole</term>
<term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Manitoba</li>
</region>
<settlement><li>Winnipeg</li>
</settlement>
<orgName><li>Université du Manitoba</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Manitoba"><name sortKey="Hobson, D E" sort="Hobson, D E" uniqKey="Hobson D" first="D. E." last="Hobson">D. E. Hobson</name>
</region>
<name sortKey="Martin, W R W" sort="Martin, W R W" uniqKey="Martin W" first="W. R. W." last="Martin">W. R. W. Martin</name>
<name sortKey="Pourcher, E" sort="Pourcher, E" uniqKey="Pourcher E" first="E." last="Pourcher">E. Pourcher</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003801 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003801 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:99-0456205
   |texte=   Ropinirole and pramipexole, the new agonists
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Ropinirole and pramipexole, the new agonists

Ropinirole and pramipexole, the new agonists

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.